Provided by Tiger Trade Technology Pte. Ltd.

Evaxion Biotech A/S

3.83
+0.01000.26%
Post-market: 3.58-0.2501-6.53%18:33 EDT
Volume:25.84K
Turnover:99.65K
Market Cap:31.80M
PE:-3.18
High:3.97
Open:3.83
Low:3.76
Close:3.82
52wk High:12.15
52wk Low:1.20
Shares:8.30M
Float Shares:5.53M
Volume Ratio:0.44
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2027
EPS(LYR):-1.2027
ROE:-100.18%
ROA:-28.23%
PB:1.87
PE(LYR):-3.18

Loading ...

Evaxion Biotech Q3 Basic EPS USD 0.01

Reuters
·
Nov 20, 2025

Evaxion Biotech Increases Share Capital Following Warrant Exercise

TIPRANKS
·
Nov 19, 2025

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading

MT Newswires Live
·
Nov 14, 2025

Evaxion A/S Announces 2026 Financial Calendar

TIPRANKS
·
Nov 12, 2025

Evaxion A/S to Report Full Year 2025 Financial Results

Reuters
·
Nov 12, 2025

Evaxion Biotech’s Earnings Call Highlights Strategic Growth

TIPRANKS
·
Nov 08, 2025

Evaxion Unveils New Immune Data From Phase 2 Trial of AI-Designed Cancer Vaccine EVX-01

Reuters
·
Nov 08, 2025

Lake Street Keeps Their Buy Rating on Evaxion Biotech (EVAX)

TIPRANKS
·
Nov 08, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Nov 07, 2025

Evaxion A/S reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025

Evaxion Biotech Announces New CEO and Promising Vaccine Developments

TIPRANKS
·
Nov 06, 2025

Techbio firm Evaxion posts Q3 net income of $4.6 mln

Reuters
·
Nov 06, 2025

Evaxion Biotech Q3 EPS $0.01 Beats $(0.21) Estimate, Sales $7.492M Beat $2.500M Estimate

Benzinga
·
Nov 06, 2025

Evaxion A/S posts Q3 net profit of $4.6 million on revenue of $7.5 million

Reuters
·
Nov 06, 2025

BRIEF-Evaxion Biotech Q3 Basic EPS USD 0.01

Reuters
·
Nov 06, 2025

Evaxion a/S: Cash Runway Has Been Extended to Second Half of 2027

THOMSON REUTERS
·
Nov 06, 2025

Evaxion Biotech Q3 Net Income USD 4.618 Million

THOMSON REUTERS
·
Nov 06, 2025

Evaxion A/S expected to post earnings of 40 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Evaxion Unveils AI-Designed Cancer Vaccine Candidate Showing Strong Preclinical Results

Reuters
·
Nov 03, 2025

Evaxion A/S to Report Third Quarter 2025 Financial Results

Reuters
·
Oct 31, 2025